Lv4
518 积分 2025-05-22 加入
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
21天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
21天前
已完结
Guizhi Fuling capsules can alleviate bortezomib-induced peripheral neuropathy by decreasing Interleukin-6 levels to regulate mTOR pathway-induced autophagy
1个月前
已完结
Histological, histochemical and energy disorders caused by R-limonene on Aedes aegypti L. larvae (Diptera: Culicidae)
3个月前
已完结
Technological Advancements in Mosquito Repellents: Challenges and Opportunities in Plant-Based Repellents
3个月前
已完结
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
7个月前
已完结
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
1年前
已完结
皖公网安备34019202002308
